Performing axillary dissection and positivity in more than 3 nodes were found to be statistically significant with a percentage of 63.3% (n=15) and 64.7% (n=11) p=0.049 and p<0.001, respectively.Conclusion: Periodic measurements with bio impedance spectroscopy can be an effective method to diagnose early stage lymphedema after breast cancer, and enable selecting the group of patients who would benefit from early treatment.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Breast cancer-related lymphedema is an important health problem. fte aim of this study is to ensure early diagnosis of patients at risk of developing lymphedema and revealing the predisposing factors.Materials and Methods: Measurements in the pre-operative period and in postoperative months 3, 6, 9 and 12 and years 2 and 3 were per- formed prospectively with bio-impedance spectroscopy for patients treated for breast cancer between November, 2013 and November, 2016.
📊
Key Findings & Data:Demo- graphic and clinical-pathological data of the patients were investigated to assess the factors that affect the development of lymphedema.Results: 245 measurements were obtained from the 67 patients who participated in the study.18 (26.8%) patients were diagnosed with lymphedema and 16 (89%) of these patients were clinically diagnosed with stage 0 and 2 (1%) patients with stage 1 lymphedema. fte median age was 50.7(32-77) years.
💡
Conclusion & Impact:Performing axillary dissection and positivity in more than 3 nodes were found to be statistically significant with a percentage of 63.3% (n=15) and 64.7% (n=11) p=0.049 and p<0.001, respectively.Conclusion: Periodic measurements with bio impedance spectroscopy can be an effective method to diagnose early stage lymphedema after breast cancer, and enable selecting the group of patients who would benefit from early treatment.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters
Özet
Objective: Breast cancer-related lymphedema is an important health problem. fte aim of this study is to ensure early diagnosis of patients at risk of developing lymphedema and revealing the predisposing factors.Materials and Methods: Measurements in the pre-operative period and in postoperative months 3, 6, 9 and 12 and years 2 and 3 were per- formed prospectively with bio-impedance spectroscopy for patients treated for breast cancer between November, 2013 and November, 2016. Demo- graphic and clinical-pathological data of the patients were investigated to assess the factors that affect the development of lymphedema.Results: 245 measurements were obtained from the 67 patients who participated in the study.18 (26.8%) patients were diagnosed with lymphedema and 16 (89%) of these patients were clinically diagnosed with stage 0 and 2 (1%) patients with stage 1 lymphedema. fte median age was 50.7(32-77) years. Performing axillary dissection and positivity in more than 3 nodes were found to be statistically significant with a percentage of 63.3% (n=15) and 64.7% (n=11) p=0.049 and p<0.001, respectively.Conclusion: Periodic measurements with bio impedance spectroscopy can be an effective method to diagnose early stage lymphedema after breast cancer, and enable selecting the group of patients who would benefit from early treatment.
🔖
Cite This Article
POLAT, A. K., KARABACAK, U., MUTLU, V., TOMAK, L., BİLGİCİ, A. (2017). Early Diagnosis of Lymphedema after Breast Cancer Treatment: Bio-Impedance Spectroscopy. The Journal of Breast Health, Cilt: 13 - Sayı: 2, 83–87. https://ajindex.com/articles/362636
Shah C, Arthur D, Riutta J, Whitworth P, Vicini FA. Breast-cancer re- lated lymphedema: a review of procedure-specific incidence rates, clini- cal assessment AIDS, treatment paradigms, and risk reduction. Breast J 2012;18:357-361. (PMID: 22759095) [CrossRef] Gärtner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment-a nationwide study of prevalence and associated factors. Breast 2010;19:506-515. (PMID: 20561790) [CrossRef] International Society of Lymphology.fte diagnosis and treatment of pe- ripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013;46:1-11.
McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol 2008;26:5220-5226. (PMID: 18838708) [CrossRef] Soran A, Polat AK, Mager LG. In Breast Deisease: Management and fterapies Vol 2. Eds Adnan Aydiner, Abdullah Igci, Atilla Soran. Breast Cancer-Related Lymphedema (BCRL). Springer International Publishing Switzerland 2016, pp 853-976. Andrade M. In Lymphedema: A Concise Compendium a fteory and Practise. Eds Byung-Boong Lee, John Bergan, Stanley G Rockson. Clini- cal Diagnosis:General Overview, Springer London 2011, pp 83-125. http:/www.springer.com/cn/book/9780857295668 Cornish BH, Chapman M, ftomas BJ, Ward LC, Bunce IH, Hirst C. Early diagnosis of lymphedema in postsurgery breast cancer patients. Ann N Y Acad Sci 2000;904:571-575. (PMID: 10865807) [CrossRef] Ward LC, Czerniec S, Kilbreath SL. Quantitative bioimpedance spec- troscopy for the assessment of lymphoedema. Breast Cancer Res Treat 2009;117:541-547. (PMID: 19082708) [CrossRef] Erdogan Iyigun Z, Selamoglu D, Alco G, Pilancı KN, Ordu C, Aga- cayak F, Elbüken F, Bozdogan A, Ilgun S, Guler Uysal F, Ozmen V. Bioelectrical impedance for detecting and monitoring lymphedema in patients with breast cancer. Preliminary results of the florence nightin- gale breast study group. Lymphat Res Biol 2015; 13:40-45. (PMID: 25526543) [CrossRef ] Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, Ahrendt GM, DeGore L, Johnson R. fte importance of detection of subclinical lymphedema for the prevention of breast cancer-related clini- cal lymphedema after axillary lymph node dissection; a prospec